相似文献
1
Prostate cancer and the human papilloma virus: causative association, role of vaccines, and the impact of the COVID-19 pandemic.
Prostate Cancer Prostatic Dis. 2022 Mar;25(1):55-57. doi: 10.1038/s41391-021-00404-6. Epub 2021 Jun 18.
2
Human Papillomavirus Vaccination Before and During the COVID-19 Pandemic.
JAMA Netw Open. 2022 Sep 1;5(9):e2234000. doi: 10.1001/jamanetworkopen.2022.34000.
3
HPV prevention and control - The way forward.
Prev Med. 2022 Mar;156:106960. doi: 10.1016/j.ypmed.2022.106960. Epub 2022 Jan 20.
4
Impact of the COVID-19 Pandemic on Human Papillomavirus Vaccination in Brazil.
Int J Public Health. 2022 Mar 31;67:1604224. doi: 10.3389/ijph.2022.1604224. eCollection 2022.
5
Perception of human papilloma virus (HPV) vaccination during the COVID-19 pandemic.
Medicine (Baltimore). 2022 Oct 28;101(43):e31389. doi: 10.1097/MD.0000000000031389.
6
Disentangling the Role of Religiosity in Human Papillomavirus Vaccination Amidst COVID-19 Pandemic.
J Relig Health. 2022 Apr;61(2):1734-1749. doi: 10.1007/s10943-021-01490-5. Epub 2022 Feb 3.
7
Human Papillomavirus Vaccinations During the COVID-19 Pandemic in Middle Schools in the Rio Grande Valley of Texas.
Am J Public Health. 2022 Sep;112(9):1269-1272. doi: 10.2105/AJPH.2022.306970. Epub 2022 Jul 21.
8
Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017.
JAMA Netw Open. 2022 Mar 1;5(3):e222530. doi: 10.1001/jamanetworkopen.2022.2530.
9
Disparities in healthcare access and utilization and human papillomavirus (HPV) vaccine initiation in the United States.
Hum Vaccin Immunother. 2021 Dec 2;17(12):5390-5396. doi: 10.1080/21645515.2021.1989919. Epub 2021 Nov 4.
10
HPV Vaccination Uptake, Hesitancy, and Refusal: Observations of Health-Care Professionals During the COVID-19 Pandemic.
JNCI Cancer Spectr. 2022 Jul 1;6(4). doi: 10.1093/jncics/pkac053.
引用本文的文献
1
Human Herpes Virus Genotype and Immunological Gene Expression Profile in Prostate Cancer with Prominent Inflammation.
Int J Mol Sci. 2025 May 21;26(10):4945. doi: 10.3390/ijms26104945.
2
The Recurrence of Tracheobronchial Papillomatosis Following Prostate Cancer Diagnosis.
Cureus. 2024 Nov 25;16(11):e74450. doi: 10.7759/cureus.74450. eCollection 2024 Nov.
3
Mendelian randomization evidence based on European ancestry for the causal effects of leukocyte telomere length on prostate cancer.
Hum Genomics. 2024 Jun 3;18(1):56. doi: 10.1186/s40246-024-00622-8.
4
Human papillomavirus and prostate cancer: systematic review and meta-analysis.
Sci Rep. 2023 Oct 3;13(1):16597. doi: 10.1038/s41598-023-43767-7.
5
Characterization of Human Papilloma Virus in Prostate Cancer Patients Undergoing Radical Prostatectomy-A Prospective Study of 140 Patients.
Viruses. 2023 May 28;15(6):1264. doi: 10.3390/v15061264.
6
Highly multiplexed immune profiling throughout adulthood reveals kinetics of lymphocyte infiltration in the aging mouse prostate.
Aging (Albany NY). 2023 May 13;15(9):3356-3380. doi: 10.18632/aging.204708.
7
Does Vaccination Protect against Human Papillomavirus-Related Cancers? Preliminary Findings from the United States National Health and Nutrition Examination Survey (2011-2018).
Vaccines (Basel). 2022 Dec 10;10(12):2113. doi: 10.3390/vaccines10122113.
本文引用的文献
1
The assessment of a possible link between HPV-mediated inflammation, apoptosis, and angiogenesis in Prostate cancer.
Int Immunopharmacol. 2020 Nov;88:106913. doi: 10.1016/j.intimp.2020.106913. Epub 2020 Sep 1.
2
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019.
MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1109-1116. doi: 10.15585/mmwr.mm6933a1.
3
Evidence for a causal role by human papillomaviruses in prostate cancer - a systematic review.
Infect Agent Cancer. 2020 Jul 14;15:41. doi: 10.1186/s13027-020-00305-8. eCollection 2020.
4
Human papillomavirus and risk of prostate cancer: a systematic review and meta-analysis.
Aging Male. 2020 Jun;23(2):132-138. doi: 10.1080/13685538.2018.1455178. Epub 2018 Mar 23.
5
APOBEC3A/B deletion polymorphism and cancer risk.
Carcinogenesis. 2018 Feb 9;39(2):118-124. doi: 10.1093/carcin/bgx131.
6
High risk human papilloma viruses (HPVs) are present in benign prostate tissues before development of HPV associated prostate cancer.
Infect Agent Cancer. 2017 Aug 11;12:46. doi: 10.1186/s13027-017-0157-2. eCollection 2017.
7
Association between human papillomavirus and prostate cancer: A meta-analysis.
Oncol Lett. 2017 Aug;14(2):1855-1865. doi: 10.3892/ol.2017.6367. Epub 2017 Jun 9.
8
The epidemiology of cancers in human immunodeficiency virus infection and after organ transplantation.
Semin Oncol. 2015 Apr;42(2):247-57. doi: 10.1053/j.seminoncol.2014.12.029. Epub 2014 Dec 31.
9
Human papillomavirus and Epstein Barr virus in prostate cancer: Koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancer.
Prostate. 2013 Feb 15;73(3):236-41. doi: 10.1002/pros.22562. Epub 2012 Jul 31.
Zotero 插件